{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "TMPRSS2", "cathepsin L", "molecular docking", "molecular dynamics", "non-covalent interactions", "phytochemical inhibitors"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32842606", "DateCompleted": {"Year": "2020", "Month": "09", "Day": "07"}, "DateRevised": {"Year": "2020", "Month": "12", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "08", "Day": "22"}], "Language": ["eng"], "ELocationID": ["3822", "10.3390/molecules25173822"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "25", "Issue": "17", "PubDate": {"Year": "2020", "Month": "Aug", "Day": "22"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection.", "Abstract": {"AbstractText": ["Presently, there are no approved drugs or vaccines to treat COVID-19, which has spread to over 200 countries and at the time of writing was responsible for over 650,000 deaths worldwide. Recent studies have shown that two human proteases, TMPRSS2 and cathepsin L, play a key role in host cell entry of SARS-CoV-2. Importantly, inhibitors of these proteases were shown to block SARS-CoV-2 infection. Here, we perform virtual screening of 14,011 phytochemicals produced by Indian medicinal plants to identify natural product inhibitors of TMPRSS2 and cathepsin L. AutoDock Vina was used to perform molecular docking of phytochemicals against TMPRSS2 and cathepsin L. Potential phytochemical inhibitors were filtered by comparing their docked binding energies with those of known inhibitors of TMPRSS2 and cathepsin L. Further, the ligand binding site residues and non-covalent interactions between protein and ligand were used as an additional filter to identify phytochemical inhibitors that either bind to or form interactions with residues important for the specificity of the target proteases. This led to the identification of 96 inhibitors of TMPRSS2 and 9 inhibitors of cathepsin L among phytochemicals of Indian medicinal plants. Further, we have performed molecular dynamics (MD) simulations to analyze the stability of the protein-ligand complexes for the three top inhibitors of TMPRSS2 namely, qingdainone, edgeworoside C and adlumidine, and of cathepsin L namely, ararobinol, (+)-oxoturkiyenine and 3\u03b1,17\u03b1-cinchophylline. Interestingly, several herbal sources of identified phytochemical inhibitors have antiviral or anti-inflammatory use in traditional medicine. Further in vitro and in vivo testing is needed before clinical trials of the promising phytochemical inhibitors identified here."]}, "AuthorList": [{"Identifier": ["0000-0002-3232-3299"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Institute of Mathematical Sciences (IMSc), Chennai 600113, India."}, {"Identifier": [], "Affiliation": "Homi Bhabha National Institute (HBNI), Mumbai 400094, India."}], "LastName": "Vivek-Ananth", "ForeName": "R P", "Initials": "RP"}, {"Identifier": ["0000-0001-5854-0710"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Homi Bhabha National Institute (HBNI), Mumbai 400094, India."}, {"Identifier": [], "Affiliation": "School of Chemical Sciences, National Institute of Science Education and Research (NISER), Bhubaneswar 752050, India."}], "LastName": "Rana", "ForeName": "Abhijit", "Initials": "A"}, {"Identifier": ["0000-0002-8115-6634"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Institute of Mathematical Sciences (IMSc), Chennai 600113, India."}], "LastName": "Rajan", "ForeName": "Nithin", "Initials": "N"}, {"Identifier": ["0000-0003-0791-2259"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Homi Bhabha National Institute (HBNI), Mumbai 400094, India."}, {"Identifier": [], "Affiliation": "School of Chemical Sciences, National Institute of Science Education and Research (NISER), Bhubaneswar 752050, India."}], "LastName": "Biswal", "ForeName": "Himansu S", "Initials": "HS"}, {"Identifier": ["0000-0002-6796-9604"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Institute of Mathematical Sciences (IMSc), Chennai 600113, India."}, {"Identifier": [], "Affiliation": "Homi Bhabha National Institute (HBNI), Mumbai 400094, India."}], "LastName": "Samal", "ForeName": "Areejit", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Coumarins"}, {"RegistryNumber": "0", "NameOfSubstance": "Monosaccharides"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Quinazolines"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Virus"}, {"RegistryNumber": "0", "NameOfSubstance": "edgeworoside C"}, {"RegistryNumber": "97457-31-3", "NameOfSubstance": "qingdainone"}, {"RegistryNumber": "EC 3.4.21.-", "NameOfSubstance": "Serine Endopeptidases"}, {"RegistryNumber": "EC 3.4.21.-", "NameOfSubstance": "TMPRSS2 protein, human"}, {"RegistryNumber": "EC 3.4.22.15", "NameOfSubstance": "CTSL protein, human"}, {"RegistryNumber": "EC 3.4.22.15", "NameOfSubstance": "Cathepsin L"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Amino Acid Sequence"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["drug effects", "pathogenicity"], "DescriptorName": "Betacoronavirus"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": ["antagonists & inhibitors", "chemistry", "genetics", "metabolism"], "DescriptorName": "Cathepsin L"}, {"QualifierName": ["drug therapy", "enzymology", "virology"], "DescriptorName": "Coronavirus Infections"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Coumarins"}, {"QualifierName": [], "DescriptorName": "Gene Expression"}, {"QualifierName": [], "DescriptorName": "High-Throughput Screening Assays"}, {"QualifierName": ["drug effects", "genetics"], "DescriptorName": "Host-Pathogen Interactions"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "India"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Monosaccharides"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug therapy", "enzymology", "virology"], "DescriptorName": "Pneumonia, Viral"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": [], "DescriptorName": "Protein Conformation, alpha-Helical"}, {"QualifierName": [], "DescriptorName": "Protein Conformation, beta-Strand"}, {"QualifierName": [], "DescriptorName": "Protein Interaction Domains and Motifs"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Quinazolines"}, {"QualifierName": ["antagonists & inhibitors", "chemistry", "genetics", "metabolism"], "DescriptorName": "Receptors, Virus"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["chemistry", "genetics", "metabolism"], "DescriptorName": "Serine Endopeptidases"}, {"QualifierName": [], "DescriptorName": "Thermodynamics"}, {"QualifierName": ["drug effects"], "DescriptorName": "Virus Internalization"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506. doi: 10.1016/S0140-6736(20)30183-5.", "ArticleIdList": ["10.1016/S0140-6736(20)30183-5", "PMC7159299", "31986264"]}, {"Citation": "Wang C., Horby P.W., Hayden F.G., Gao G.F. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470\u2013473. doi: 10.1016/S0140-6736(20)30185-9.", "ArticleIdList": ["10.1016/S0140-6736(20)30185-9", "PMC7135038", "31986257"]}, {"Citation": "Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727\u2013733. doi: 10.1056/NEJMoa2001017.", "ArticleIdList": ["10.1056/NEJMoa2001017", "PMC7092803", "31978945"]}, {"Citation": "Chan J.F.-W., Yuan S., Kok K.-H., To K.K.-W., Chu H., Yang J., Xing F., Liu J., Yip C.C.-Y., Poon R.W.-S., et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet. 2020;395:514\u2013523. doi: 10.1016/S0140-6736(20)30154-9.", "ArticleIdList": ["10.1016/S0140-6736(20)30154-9", "PMC7159286", "31986261"]}, {"Citation": "Li W. Bats Are Natural Reservoirs of SARS-Like Coronaviruses. Science. 2005;310:676\u2013679. doi: 10.1126/science.1118391.", "ArticleIdList": ["10.1126/science.1118391", "16195424"]}, {"Citation": "Zhou P., Yang X.-L., Wang X.-G., Hu B., Zhang L., Zhang W., Si H.-R., Zhu Y., Li B., Huang C.-L., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270\u2013273. doi: 10.1038/s41586-020-2012-7.", "ArticleIdList": ["10.1038/s41586-020-2012-7", "PMC7095418", "32015507"]}, {"Citation": "De Wit E., Van Doremalen N., Falzarano D., Munster V. SARS and MERS: Recent insights into emerging coronaviruses. Nat. Rev. Genet. 2016;14:523\u2013534. doi: 10.1038/nrmicro.2016.81.", "ArticleIdList": ["10.1038/nrmicro.2016.81", "PMC7097822", "27344959"]}, {"Citation": "Li G., De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Nat. Rev. Drug Discov. 2020;19:149\u2013150. doi: 10.1038/d41573-020-00016-0.", "ArticleIdList": ["10.1038/d41573-020-00016-0", "32127666"]}, {"Citation": "Wu A., Peng Y., Huang B., Ding X., Wang X., Niu P., Meng J., Zhu Z., Zhang Z., Wang J., et al. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. Cell Host Microbe. 2020;27:325\u2013328. doi: 10.1016/j.chom.2020.02.001.", "ArticleIdList": ["10.1016/j.chom.2020.02.001", "PMC7154514", "32035028"]}, {"Citation": "Hoffmann M., Kleine-Weber H., Schroeder S., Kr\u00fcger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.-H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271\u2013280.e8. doi: 10.1016/j.cell.2020.02.052.", "ArticleIdList": ["10.1016/j.cell.2020.02.052", "PMC7102627", "32142651"]}, {"Citation": "Ou X., Liu Y., Lei X., Li P., Mi D., Ren L., Guo L., Guo R., Chen T., Hu J., et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat. Commun. 2020;11:1620. doi: 10.1038/s41467-020-15562-9.", "ArticleIdList": ["10.1038/s41467-020-15562-9", "PMC7100515", "32221306"]}, {"Citation": "Shang J., Wan Y., Luo C., Ye G., Geng Q., Auerbach A., Li F. Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. USA. 2020;117:11727\u201311734. doi: 10.1073/pnas.2003138117.", "ArticleIdList": ["10.1073/pnas.2003138117", "PMC7260975", "32376634"]}, {"Citation": "Shang J., Ye G., Shi K., Wan Y., Luo C., Aihara H., Geng Q., Auerbach A., Li F. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581:221\u2013224. doi: 10.1038/s41586-020-2179-y.", "ArticleIdList": ["10.1038/s41586-020-2179-y", "PMC7328981", "32225175"]}, {"Citation": "Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367:1444\u20131448. doi: 10.1126/science.abb2762.", "ArticleIdList": ["10.1126/science.abb2762", "PMC7164635", "32132184"]}, {"Citation": "Hoffmann M., Schroeder S., Kleine-Weber H., M\u00fcller M.A., Drosten C., P\u00f6hlmann S. Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19. Antimicrob. Agents Chemother. 2020;64:64. doi: 10.1128/AAC.00754-20.", "ArticleIdList": ["10.1128/AAC.00754-20", "PMC7269515", "32312781"]}, {"Citation": "Wu C., Liu Y., Yang Y., Zhang P., Zhong W., Wang Y., Wang Q., Xu Y., Li M., Li X., et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm. Sin. B. 2020;10:766\u2013788. doi: 10.1016/j.apsb.2020.02.008.", "ArticleIdList": ["10.1016/j.apsb.2020.02.008", "PMC7102550", "32292689"]}, {"Citation": "ElFiky A.A. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sci. 2020;253:117592. doi: 10.1016/j.lfs.2020.117592.", "ArticleIdList": ["10.1016/j.lfs.2020.117592", "PMC7102646", "32222463"]}, {"Citation": "Islam R., Parves R., Paul A.S., Uddin N., Rahman S., Al Mamun A., Hossain N., Ali A., Halim M.A. A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. J. Biomol. Struct. Dyn. 2020:1\u201312. doi: 10.1080/07391102.2020.1761883.", "ArticleIdList": ["10.1080/07391102.2020.1761883", "PMC7232885", "32340562"]}, {"Citation": "Rahman N., Basharat Z., Yousuf M., Castaldo G., Rastrelli L., Khan H. Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2) Molecules. 2020;25:2271. doi: 10.3390/molecules25102271.", "ArticleIdList": ["10.3390/molecules25102271", "PMC7287752", "32408547"]}, {"Citation": "Shah B., Modi P., Sagar S.R. In silico studies on therapeutic agents for COVID-19: Drug repurposing approach. Life Sci. 2020;252:117652. doi: 10.1016/j.lfs.2020.117652.", "ArticleIdList": ["10.1016/j.lfs.2020.117652", "PMC7194845", "32278693"]}, {"Citation": "Kumar A., Choudhir G., Shukla S.K., Sharma M., Tyagi P., Bhushan A., Rathore M. Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches. J. Biomol. Struct. Dyn. 2020:1\u201311. doi: 10.1080/07391102.2020.1772112.", "ArticleIdList": ["10.1080/07391102.2020.1772112", "PMC7284142", "32448034"]}, {"Citation": "Liu S., Zheng Q., Wang Z. Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus. Bioinformatics. 2020;36:3295\u20133298. doi: 10.1093/bioinformatics/btaa224.", "ArticleIdList": ["10.1093/bioinformatics/btaa224", "PMC7184403", "32239142"]}, {"Citation": "Olubiyi O.O., Olagunju M.O., Keutmann M., Loschwitz J., Strodel B. High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2. Molecules. 2020;25:3193. doi: 10.3390/molecules25143193.", "ArticleIdList": ["10.3390/molecules25143193", "PMC7396980", "32668701"]}, {"Citation": "Ahmad M., Dwivedy A., Mariadasse R., Tiwari S., Kar D., Jeyakanthan J., Biswal B.K. Prediction of Small Molecule Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus-2 RNA-dependent RNA Polymerase. ACS Omega. 2020 doi: 10.1021/acsomega.0c02096.", "ArticleIdList": ["10.1021/acsomega.0c02096", "PMC7391942", "32743211"]}, {"Citation": "Newman D.J., Cragg G.M. Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010. J. Nat. Prod. 2012;75:311\u2013335. doi: 10.1021/np200906s.", "ArticleIdList": ["10.1021/np200906s", "PMC3721181", "22316239"]}, {"Citation": "Ren J.-L., Zhang A.-H., Wang X.-J. Traditional Chinese medicine for COVID-19 treatment. Pharmacol. Res. 2020;155:104743. doi: 10.1016/j.phrs.2020.104743.", "ArticleIdList": ["10.1016/j.phrs.2020.104743", "PMC7128263", "32145402"]}, {"Citation": "Vellingiri B., Jayaramayya K., Iyer M., Narayanasamy A., Govindasamy V., Giridharan B., Ganesan S., Venugopal A., Venkatesan D., Ganesan H., et al. COVID-19: A promising cure for the global panic. Sci. Total Environ. 2020;725:138277. doi: 10.1016/j.scitotenv.2020.138277.", "ArticleIdList": ["10.1016/j.scitotenv.2020.138277", "PMC7128376", "32278175"]}, {"Citation": "Mohanraj K., Karthikeyan B.S., Vivek-Ananth R.P., Chand R.P.B., Aparna S.R., Mangalapandi P., Samal A. IMPPAT: A curated database of Indian Medicinal Plants, Phytochemistry And Therapeutics. Sci. Rep. 2018;8:4329. doi: 10.1038/s41598-018-22631-z.", "ArticleIdList": ["10.1038/s41598-018-22631-z", "PMC5847565", "29531263"]}, {"Citation": "Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 2001;46:3\u201326. doi: 10.1016/S0169-409X(00)00129-0.", "ArticleIdList": ["10.1016/S0169-409X(00)00129-0", "11259830"]}, {"Citation": "Kim S., Chen J., Cheng T., Gindulyte A., He J., He S., Li Q., Shoemaker B.A., Thiessen P.A., Yu B., et al. PubChem 2019 update: Improved access to chemical data. Nucleic Acids Res. 2018;47:D1102\u2013D1109. doi: 10.1093/nar/gky1033.", "ArticleIdList": ["10.1093/nar/gky1033", "PMC6324075", "30371825"]}, {"Citation": "O\u2019Boyle N., Banck M., James C.A., Morley C., Vandermeersch T., Hutchison G.R. Open Babel: An open chemical toolbox. J. Cheminformatics. 2011;3:33. doi: 10.1186/1758-2946-3-33.", "ArticleIdList": ["10.1186/1758-2946-3-33", "PMC3198950", "21982300"]}, {"Citation": "Waterhouse A., Bertoni M., Bienert S., Studer G., Tauriello G., Gumienny R., Heer F.T., Beer T.A.P.D., Rempfer C., Bordoli L., et al. SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46:W296\u2013W303. doi: 10.1093/nar/gky427.", "ArticleIdList": ["10.1093/nar/gky427", "PMC6030848", "29788355"]}, {"Citation": "Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera--a visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605\u20131612. doi: 10.1002/jcc.20084.", "ArticleIdList": ["10.1002/jcc.20084", "15264254"]}, {"Citation": "Trott O., Olson A.J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2009;31:455\u2013461. doi: 10.1002/jcc.21334.", "ArticleIdList": ["10.1002/jcc.21334", "PMC3041641", "19499576"]}, {"Citation": "Paoloni-Giacobino A., Chen H., Peitsch M.C., Rossier C., Antonarakis S.E. Cloning of the TMPRSS2 Gene, Which Encodes a Novel Serine Protease with Transmembrane, LDLRA, and SRCR Domains and Maps to 21q22.3. Genomics. 1997;44:309\u2013320. doi: 10.1006/geno.1997.4845.", "ArticleIdList": ["10.1006/geno.1997.4845", "9325052"]}, {"Citation": "Tsai Y.-C., Lee C.-L., Yen H.-R., Chang Y.-S., Lin Y.-P., Huang S.-H., Lin C.-W. Antiviral Action of Tryptanthrin Isolated from Strobilanthes cusia Leaf against Human Coronavirus NL63. Biomolecules. 2020;10:366. doi: 10.3390/biom10030366.", "ArticleIdList": ["10.3390/biom10030366", "PMC7175275", "32120929"]}, {"Citation": "Zhao D.-G., Zhou A.-Y., Du Z., Zhang Y., Zhang K., Ma Y.-Y. Coumarins with \u03b1-glucosidase and \u03b1-amylase inhibitory activities from the flower of Edgeworthia gardneri. Fitoterapia. 2015;107:122\u2013127. doi: 10.1016/j.fitote.2015.10.012.", "ArticleIdList": ["10.1016/j.fitote.2015.10.012", "26529177"]}, {"Citation": "Gao D., Zhang Y.-L., Xu P., Lin Y.-X., Yang F., Liu J.-H., Zhu H.-W., Xia Z. In vitro evaluation of dual agonists for PPAR\u03b3/\u03b2 from the flower of Edgeworthia gardneri (wall.) Meisn. J. Ethnopharmacol. 2015;162:14\u201319. doi: 10.1016/j.jep.2014.12.034.", "ArticleIdList": ["10.1016/j.jep.2014.12.034", "25557029"]}, {"Citation": "Gao D., Zhang Y.-L., Yang F., Li F., Zhang Q.-H., Xia Z.-N. The flower of Edgeworthia gardneri (wall.) Meisn. suppresses adipogenesis through modulation of the AMPK pathway in 3T3-L1 adipocytes. J. Ethnopharmacol. 2016;191:379\u2013386. doi: 10.1016/j.jep.2016.06.059.", "ArticleIdList": ["10.1016/j.jep.2016.06.059", "27350007"]}, {"Citation": "Gupta P.C., Sharma N., Rao C.V. A review on ethnobotany, phytochemistry and pharmacology of Fumaria indica (Fumitory) Asian Pac. J. Trop. Biomed. 2012;2:665\u2013669. doi: 10.1016/S2221-1691(12)60117-8.", "ArticleIdList": ["10.1016/S2221-1691(12)60117-8", "PMC3609363", "23569991"]}, {"Citation": "Kardos J., Blask\u00f3 G., Kerekes P., Kov\u00e1cs I., Simonyi M. Inhibition of [3H]GABA binding to rat brain synaptic membranes by bicuculline related alkaloids. Biochem. Pharmacol. 1984;33:3537\u20133545. doi: 10.1016/0006-2952(84)90134-5.", "ArticleIdList": ["10.1016/0006-2952(84)90134-5", "6095852"]}, {"Citation": "Chand A., Sahoo D.K., Rana A., Jena S., Biswal H.S. The Prodigious Hydrogen Bonds with Sulfur and Selenium in Molecular Assemblies, Structural Biology, and Functional Materials. Acc. Chem. Res. 2020 doi: 10.1021/acs.accounts.0c00289.", "ArticleIdList": ["10.1021/acs.accounts.0c00289", "32677432"]}, {"Citation": "Acharya R., Mitra S., Shukla V. Effect of Shodhana (processing) on Kupeelu (Strychnos nux-vomica Linn.) with special reference to strychnine and brucine content. AYU (An. Int. Q. J. Res. Ayurveda) 2011;32:402\u2013407. doi: 10.4103/0974-8520.93923.", "ArticleIdList": ["10.4103/0974-8520.93923", "PMC3326892", "22529660"]}, {"Citation": "Ueno S., Bracamontes J., Zorumski C., Weiss D.S., Steinbach J.H. Bicuculline and Gabazine Are Allosteric Inhibitors of Channel Opening of the GABAA Receptor. J. Neurosci. 1997;17:625\u2013634. doi: 10.1523/JNEUROSCI.17-02-00625.1997.", "ArticleIdList": ["10.1523/JNEUROSCI.17-02-00625.1997", "PMC6573228", "8987785"]}, {"Citation": "Khare C.P. Indian Medicinal Plants: An Illustrated Dictionary. Springer; New York, NY, USA: 2007."}, {"Citation": "Yadav J.P., Arya V., Yadav S., Panghal M., Kumar S., Dhankhar S. Cassia occidentalis L.: A review on its ethnobotany, phytochemical and pharmacological profile. Fitoterapia. 2010;81:223\u2013230. doi: 10.1016/j.fitote.2009.09.008.", "ArticleIdList": ["10.1016/j.fitote.2009.09.008", "19796670"]}, {"Citation": "Zhu S.H., Yang Z.Q., Peng X.L. Application of Anthraqinone Derivative in Resisting Influenza Virus and Bird Flu Virus H5N1. CN20051134677. China Patent. 2005 Dec 21;"}, {"Citation": "Mete I.E., G\u00f6zler T. (+)-Oxoturkiyenine: An Isoquinoline-Derived Alkaloid from Hypecoum pendulum. J. Nat. Prod. 1988;51:272\u2013274. doi: 10.1021/np50056a013.", "ArticleIdList": ["10.1021/np50056a013"]}, {"Citation": "Gurung P., De P. Spectrum of biological properties of cinchona alkaloids: A brief review. J. Pharmacogn. Phytochem. 2017;6:162\u2013166."}, {"Citation": "Tripathi Y.C., Maurya S., Singh V., Pandey V. Cyclopeptide alkaloids from Zizyphus rugosa bark. Phytochemistry. 1989;28:1563\u20131565. doi: 10.1016/S0031-9422(00)97797-5.", "ArticleIdList": ["10.1016/S0031-9422(00)97797-5"]}, {"Citation": "Yadav A., Singh P. Analgesic and anti-inflammatory activities of Zizyphus rugosa root barks. J. Chem. Pharm. Res. 2010;2:255\u2013259."}, {"Citation": "Wang J.-H., Luan F., He X.-D., Wang Y., Li M.-X. Traditional uses and pharmacological properties of Clerodendrum phytochemicals. J. Tradit. Complement. Med. 2018;8:24\u201338. doi: 10.1016/j.jtcme.2017.04.001.", "ArticleIdList": ["10.1016/j.jtcme.2017.04.001", "PMC5755984", "29321986"]}, {"Citation": "Sumthong P., Romero-Gonz\u00e1lez R.R., Verpoorte R. Identification of Anti-Wood Rot Compounds in Teak (Tectona grandisL.f.) Sawdust Extract. J. Wood Chem. Technol. 2008;28:247\u2013260. doi: 10.1080/02773810802452592.", "ArticleIdList": ["10.1080/02773810802452592"]}, {"Citation": "Jain M., Kapadia R., Jadeja R.N., Thounaojam M.C., Devkar R.V., Mishra S.H. Traditional uses, phytochemistry and pharmacology of Tecomella undulata\u2014A review. Asian Pac. J. Trop. Biomed. 2012;2:1918. doi: 10.1016/S2221-1691(12)60521-8.", "ArticleIdList": ["10.1016/S2221-1691(12)60521-8"]}, {"Citation": "Cadelis M., Bourguet-Kondracki M.-L., Dubois J., Valentin A., Barker D., Copp B.R. Discovery and preliminary structure\u2013activity relationship studies on tecomaquinone I and tectol as novel farnesyltransferase and plasmodial inhibitors. Bioorganic Med. Chem. 2016;24:3102\u20133107. doi: 10.1016/j.bmc.2016.05.024.", "ArticleIdList": ["10.1016/j.bmc.2016.05.024", "27240468"]}, {"Citation": "Bosisio E. Effect of the flavanolignans of Silybum marianum L. On lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes. Pharmacol. Res. 1992;25:147\u2013165. doi: 10.1016/1043-6618(92)91383-R.", "ArticleIdList": ["10.1016/1043-6618(92)91383-R", "1635893"]}, {"Citation": "Bahmani M., Shirzad H., Rafieian S., Rafieian-Kopaei M. Silybum marianum: Beyond Hepatoprotection. J. Evid. -Based Complementary Altern. Med. 2015;20:292\u2013301. doi: 10.1177/2156587215571116.", "ArticleIdList": ["10.1177/2156587215571116", "25686616"]}, {"Citation": "Genheden S., Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin. Drug Discov. 2015;10:449\u2013461. doi: 10.1517/17460441.2015.1032936.", "ArticleIdList": ["10.1517/17460441.2015.1032936", "PMC4487606", "25835573"]}, {"Citation": "Baker N.A., Sept D., Joseph S., Holst M.J., McCammon J.A. Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc. Natl. Acad. Sci. USA. 2001;98:10037\u201310041. doi: 10.1073/pnas.181342398.", "ArticleIdList": ["10.1073/pnas.181342398", "PMC56910", "11517324"]}, {"Citation": "Kumari R., Kumar R., Lynn A. Open Source Drug Discovery Consortium g_mmpbsa\u2014A GROMACS Tool for High-Throughput MM-PBSA Calculations. J. Chem. Inf. Model. 2014;54:1951\u20131962. doi: 10.1021/ci500020m.", "ArticleIdList": ["10.1021/ci500020m", "24850022"]}, {"Citation": "The Wealth of India the wealth of India: A Dictionary of Indian Raw Materials & Industrial Products. First Supplement Series (Raw Materials) Volume 1 Publications & Information Directorate, Council of Scientific & Industrial Research; New Delhi, India: 2000."}, {"Citation": "The Wealth of India the Wealth of India: A Dictionary of Indian Raw Materials & Industrial Products. First Supplement Series (Raw Materials) Volume 2 Publications & Information Directorate, Council of Scientific & Industrial Research; New Delhi, India: 2000."}, {"Citation": "The Wealth of India the wealth of India: A Dictionary of Indian Raw Materials & Industrial Products. First Supplement Series (Raw Materials) Volume 3 Publications & Information Directorate, Council of Scientific & Industrial Research; New Delhi, India: 2000."}, {"Citation": "The Wealth of India the Wealth of India: A Dictionary of Indian Raw Materials & Industrial Products. First Supplement Series (Raw Materials) Volume 4 Publications & Information Directorate, Council of Scientific & Industrial Research; New Delhi, India: 2000."}, {"Citation": "The Wealth of India the Wealth of India: A Dictionary of Indian Raw Materials & Industrial Products. First Supplement Series (Raw Materials) Volume 5 Publications & Information Directorate, Council of Scientific & Industrial Research; New Delhi, India: 2000."}, {"Citation": "Rastogi R.P., editor. Compendium of Indian Medicinal Plants. Volume 1. Central Drug Research Institute; Lucknow, India: 1990. Drug Research Perspectives; pp. 1960\u20131969."}, {"Citation": "Rastogi R.P., editor. Compendium of Indian Medicinal Plants. Volume 2. Central Drug Research Institute; Lucknow, India: 1991. Drug Research Perspectives; pp. 1970\u20131979."}, {"Citation": "Rastogi R.P., editor. Compendium of Indian Medicinal Plants. Volume 3. Central Drug Research Institute; Lucknow, India: 1993. Drug Research Perspectives; pp. 1980\u20131984."}, {"Citation": "Rastogi R.P., editor. Compendium of Indian Medicinal Plants. Volume 4. Central Drug Research Institute; Lucknow, India: 1995. Drug Research Perspectives; pp. 1985\u20131989."}, {"Citation": "Rastogi R.P., editor. Compendium of Indian Medicinal Plants. Volume 5. Central Drug Research Institute; Lucknow, India: 1998. Drug Research Perspectives; pp. 1990\u20131994."}, {"Citation": "Evnin L.B., Vasquez J.R., Craik C.S. Substrate specificity of trypsin investigated by using a genetic selection. Proc. Natl. Acad. Sci. USA. 1990;87:6659\u20136663. doi: 10.1073/pnas.87.17.6659.", "ArticleIdList": ["10.1073/pnas.87.17.6659", "PMC54596", "2204062"]}, {"Citation": "Herter S., Piper D.E., Aaron W., Gabriele T., Cutler G., Cao P., Bhatt A.S., Choe Y., Craik C.S., Walker N., et al. Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. Biochem. J. 2005;390:125\u2013136. doi: 10.1042/BJ20041955.", "ArticleIdList": ["10.1042/BJ20041955", "PMC1184568", "15839837"]}, {"Citation": "Chen V.B., Arendall W.B., Headd J.J., Keedy D.A., Immormino R.M., Kapral G.J., Murray L.W., Richardson J.S., Richardson D.C. MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallogr. Sect. D Biol. Crystallogr. 2010;66:12\u201321. doi: 10.1107/S0907444909042073.", "ArticleIdList": ["10.1107/S0907444909042073", "PMC2803126", "20057044"]}, {"Citation": "Kuhn B., Tich\u00fd M., Wang L., Robinson S., Martin R.E., Kuglstatter A., Benz J., Giroud M., Schirmeister T., Abel R., et al. Prospective Evaluation of Free Energy Calculations for the Prioritization of Cathepsin L Inhibitors. J. Med. Chem. 2017;60:2485\u20132497. doi: 10.1021/acs.jmedchem.6b01881.", "ArticleIdList": ["10.1021/acs.jmedchem.6b01881", "28287264"]}, {"Citation": "Fujishima A., Imai Y., Nomura T., Fujisawa Y., Yamamoto Y., Sugawara T. The crystal structure of human cathepsin L complexed with E-64. FEBS Lett. 1997;407:47\u201350. doi: 10.1016/S0014-5793(97)00216-0.", "ArticleIdList": ["10.1016/S0014-5793(97)00216-0", "9141479"]}, {"Citation": "Turk V., Stoka V., Vasiljeva O., Renko M., Sun T., Turk B., Turk D. Cysteine cathepsins: From structure, function and regulation to new frontiers. Biochim. Biophys. Acta (BBA)-Proteins Proteom. 2012;1824:68\u201388. doi: 10.1016/j.bbapap.2011.10.002.", "ArticleIdList": ["10.1016/j.bbapap.2011.10.002", "PMC7105208", "22024571"]}, {"Citation": "Adams-Cioaba M.A., Krupa J.C., Xu C., Mort J.S., Min J. Structural basis for the recognition and cleavage of histone H3 by cathepsin L. Nat. Commun. 2011;2:197. doi: 10.1038/ncomms1204.", "ArticleIdList": ["10.1038/ncomms1204", "PMC3105313", "21326229"]}, {"Citation": "Morris G., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S., Olson A.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009;30:2785\u20132791. doi: 10.1002/jcc.21256.", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Rodrigues J.P., Mc Teixeira J., Trellet M., Bonvin A.M.J.J. pdb-tools: A swiss army knife for molecular structures. F1000Research. 2018;7:1961. doi: 10.12688/f1000research.17456.1.", "ArticleIdList": ["10.12688/f1000research.17456.1", "PMC6343223", "30705752"]}, {"Citation": "Schmidt T., Haas J., Cassarino T.G., Schwede T. Assessment of ligand-binding residue predictions in CASP9. Proteins Struct. Funct. Bioinform. 2011;79:126\u2013136. doi: 10.1002/prot.23174.", "ArticleIdList": ["10.1002/prot.23174", "PMC5628505", "21987472"]}, {"Citation": "Sarkhel S., Desiraju G.R. N-H\u2026O, O-H\u2026O, and C-H\u2026O hydrogen bonds in protein-ligand complexes: Strong and weak interactions in molecular recognition. Proteins Struct. Funct. Bioinform. 2003;54:247\u2013259. doi: 10.1002/prot.10567.", "ArticleIdList": ["10.1002/prot.10567", "14696187"]}, {"Citation": "Zhou P., Tian F., Lv F., Shang Z. Geometric characteristics of hydrogen bonds involving sulfur atoms in proteins. Proteins Struct. Funct. Bioinform. 2008;76:151\u2013163. doi: 10.1002/prot.22327.", "ArticleIdList": ["10.1002/prot.22327", "19089987"]}, {"Citation": "K\u0159\u00ed\u017e K., Fanfrlik J., Lepsik M. Chalcogen Bonding in Protein\u2212Ligand Complexes: PDB Survey and Quantum Mechanical Calculations. Chem. Phys. Chem. 2018;19:2540\u20132548. doi: 10.1002/cphc.201800409.", "ArticleIdList": ["10.1002/cphc.201800409", "30003638"]}, {"Citation": "Borozan S., Stojanovi\u0107 S.\u0110. Halogen bonding in complexes of proteins and non-natural amino acids. Comput. Biol. Chem. 2013;47:231\u2013239. doi: 10.1016/j.compbiolchem.2013.10.002.", "ArticleIdList": ["10.1016/j.compbiolchem.2013.10.002", "24200696"]}, {"Citation": "De Freitas R.F., Schapira M. A systematic analysis of atomic protein\u2013ligand interactions in the PDB\u2020 \u2020Electronic supplementary information (ESI) available. See doi:10.1039/c7md00381a. Med. Chem. Comm. 2017;8:1970\u20131981. doi: 10.1039/C7MD00381A.", "ArticleIdList": ["10.1039/C7MD00381A", "PMC5708362", "29308120"]}, {"Citation": "Turk V., Turk B., Turk D. NEW EMBO MEMBERS\u2019 REVIEW: Lysosomal cysteine proteases: Facts and opportunities. EMBO J. 2001;20:4629\u20134633. doi: 10.1093/emboj/20.17.4629.", "ArticleIdList": ["10.1093/emboj/20.17.4629", "PMC125585", "11532926"]}, {"Citation": "Liu T., Luo S., Libby P., Shi G. Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients. Pharmacol. Ther. 2020;213:107587. doi: 10.1016/j.pharmthera.2020.107587.", "ArticleIdList": ["10.1016/j.pharmthera.2020.107587", "PMC7255230", "32470470"]}, {"Citation": "Abraham M., Murtola T., Schulz R., P\u00e1ll S., Smith J.C., Hess B., Lindahl E. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015:19\u201325. doi: 10.1016/j.softx.2015.06.001.", "ArticleIdList": ["10.1016/j.softx.2015.06.001"]}, {"Citation": "Schmid N., Eichenberger A.P., Choutko A., Riniker S., Winger M., Mark A.E., Van Gunsteren W.F. Definition and testing of the GROMOS force-field versions 54A7 and 54B7. Eur. Biophys. J. 2011;40:843\u2013856. doi: 10.1007/s00249-011-0700-9.", "ArticleIdList": ["10.1007/s00249-011-0700-9", "21533652"]}, {"Citation": "Stroet M., Caron B., Visscher K.M., Geerke D.P., Malde A.K., Mark A.E. Automated Topology Builder Version 3.0: Prediction of Solvation Free Enthalpies in Water and Hexane. J. Chem. Theory Comput. 2018;14:5834\u20135845. doi: 10.1021/acs.jctc.8b00768.", "ArticleIdList": ["10.1021/acs.jctc.8b00768", "30289710"]}, {"Citation": "Berendsen H.J.C., Postma J.P.M., Van Gunsteren W.F., DiNola A., Haak J.R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 1984;81:3684\u20133690. doi: 10.1063/1.448118.", "ArticleIdList": ["10.1063/1.448118"]}, {"Citation": "Parrinello M. Polymorphic transitions in single crystals: A new molecular dynamics method. J. Appl. Phys. 1981;52:7182. doi: 10.1063/1.328693.", "ArticleIdList": ["10.1063/1.328693"]}, {"Citation": "Daina A., Michielin O., Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 2017;7:42717. doi: 10.1038/srep42717.", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "Schyman P., Liu R., Desai V., Wallqvist A. vNN Web Server for ADMET Predictions. Front. Pharmacol. 2017;8:889. doi: 10.3389/fphar.2017.00889.", "ArticleIdList": ["10.3389/fphar.2017.00889", "PMC5722789", "29255418"]}, {"Citation": "Yuan H., Ma Q., Ye L., Piao G. The Traditional Medicine and Modern Medicine from Natural Products. Molecules. 2016;21:559. doi: 10.3390/molecules21050559.", "ArticleIdList": ["10.3390/molecules21050559", "PMC6273146", "27136524"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "7", "Day": "27"}, {"Year": "2020", "Month": "8", "Day": "15"}, {"Year": "2020", "Month": "8", "Day": "16"}, {"Year": "2020", "Month": "8", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["32842606", "PMC7504347", "10.3390/molecules25173822", "molecules25173822"]}}], "PubmedBookArticle": []}